Current management of CML patients: Summary of the Italian Consensus Meeting held in Rome, April 11–12, 2013

Abstract Treatment of Chronic Myeloid Leukaemia (CML) has evolved rapidly in the last 10 years. The objectives of this national consensus meeting were to describe the optimal procedures to perform at diagnosis, the most appropriate choice of tyrosine kinase inhibitor (TKI) in the first line setting,...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Critical reviews in oncology/hematology 2014-06, Vol.90 (3), p.181-189
Hauptverfasser:	Breccia, Massimo, Alimena, Giuliana, Baccarani, Michele, Bocchia, Monica, Di Raimondo, Francesco, Gambacorti-Passerini, Carlo, Gozzini, Antonella, Morra, Enrica, Pane, Fabrizio, Pregno, Patrizia, Rege-Cambrin, Giovanna, Rosti, Gianantonio, Specchia, Giorgina, Vigneri, Paolo, Saglio, Giuseppe
Format:	Artikel
Sprache:	eng
Schlagworte:	Chronic myeloid leukaemia Disease Management Hematology, Oncology and Palliative Medicine Humans Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy Monitoring Therapeutic objectives Treatment discontinuation Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!